Phathom Pharmaceuticals Inc to Discuss The FDA Approval Transcript - Thomson StreetEvents

Phathom Pharmaceuticals Inc to Discuss The FDA Approval Transcript

Phathom Pharmaceuticals Inc to Discuss The FDA Approval Transcript - Thomson StreetEvents
Phathom Pharmaceuticals Inc to Discuss The FDA Approval Transcript
Published Nov 02, 2023
14 pages (9244 words) — Published Nov 02, 2023
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of PHAT.OQ conference call or presentation 2-Nov-23 3:00pm GMT

  
Brief Excerpt:

...Operator Welcome to the Phathom Pharmaceuticals FDA Approval Conference Call. (Operator Instructions) Please be advised that today's call is being recorded. With that, I would like to turn the conference call over to Eric Sciorilli, Head of Investor Relations. Please go ahead. Eric Sciorilli Thank you, operator. Hello, everyone, and thank you all for joining us this morning to discuss our recent FDA approvals. Just a couple of logistical items before we get started. A recording of today's webcast and presentation can be found under the Events and Presentations section of our corporate website. Also, before we begin, let me remind you that we will be making a number of forward-looking statements throughout today's presentation. These forward-looking statements involve risks and uncertainties, many of which are beyond Phathom's control. Actual results can materially differ from the forward-looking statements, and any such risks can materially adversely affect the business, the results of...

  
Report Type:

Transcript

Source:
Company:
Phathom Pharmaceuticals Inc
Ticker
PHAT.OQ
Time
3:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Phathom Pharmaceuticals Inc Q1 2025 Earnings Call Transcript – 2025-05-01 – US$ 106.00 – Edited Transcript of PHAT.OQ earnings conference call or presentation 1-May-25 12:00pm GMT

Phathom Pharmaceuticals Inc Q4 2024 Earnings Call Transcript – 2025-03-06 – US$ 54.00 – Edited Transcript of PHAT.OQ earnings conference call or presentation 6-Mar-25 1:30pm GMT

Phathom Pharmaceuticals Inc Q3 2024 Earnings Call Transcript – 2024-11-07 – US$ 54.00 – Edited Transcript of PHAT.OQ earnings conference call or presentation 7-Nov-24 1:30pm GMT

Phathom Pharmaceuticals Inc at Goldman Sachs Global Healthcare Conference Transcript – 2024-06-11 – US$ 54.00 – Edited Transcript of PHAT.OQ presentation 11-Jun-24 6:40pm GMT

Phathom Pharmaceuticals Inc Annual Shareholders Meeting Transcript – 2024-05-23 – US$ 54.00 – Edited Transcript of PHAT.OQ shareholder or annual meeting 23-May-24 2:00pm GMT

Phathom Pharmaceuticals Inc at Goldman Sachs Healthcare Conference Transcript – 2023-06-14 – US$ 54.00 – Edited Transcript of PHAT.OQ presentation 14-Jun-23 3:00pm GMT

Phathom Pharmaceuticals Inc at Needham Healthcare Conference (Virtual) Transcript – 2023-04-18 – US$ 54.00 – Edited Transcript of PHAT.OQ presentation 18-Apr-23 12:45pm GMT

Phathom Pharmaceuticals Inc at Needham Healthcare Conference (Virtual) Transcript – 2022-04-12 – US$ 54.00 – Edited Transcript of PHAT.OQ presentation 12-Apr-22 1:30pm GMT

Phathom Pharmaceuticals Inc Conference call on the PHALCON-EE Trial Results Transcript – 2021-10-18 – US$ 54.00 – Edited Transcript of PHAT.OQ conference call or presentation 18-Oct-21 12:30pm GMT

Phathom Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript – 2021-09-14 – US$ 54.00 – Edited Transcript of PHAT.OQ presentation 14-Sep-21 3:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Phathom Pharmaceuticals Inc to Discuss The FDA Approval Transcript" Nov 02, 2023. Alacra Store. May 03, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Phathom-Pharmaceuticals-Inc-to-Discuss-The-FDA-Approval-T15793833>
  
APA:
Thomson StreetEvents. (2023). Phathom Pharmaceuticals Inc to Discuss The FDA Approval Transcript Nov 02, 2023. New York, NY: Alacra Store. Retrieved May 03, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Phathom-Pharmaceuticals-Inc-to-Discuss-The-FDA-Approval-T15793833>
  
US$ 54.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.